Dr. Howard Smith Oncall

Vidcast: https://youtu.be/_HW1iHftI3o New developments for:   Skin Cancer, Pancreatic Cancer, Stroke, Pediatric Heart Disease, Male Contraception, Genetic Engineering All this on  Medicine of the Future. Researchers at the Ohio State Comprehensive  Cancer Center suggest that the already available and inexpensive neurodrug dopamine can reduce the development of common skin cancers including basal cell and squamous cell carcinomas. Testing this drug in mice, it stimulates receptors in the cell that block the cancer-inducing effects of ultraviolet light.  The drug could be a godsend for those with light-complexions and a propensity for skin cancer   University of Pennsylvania oncologists report a preliminary phase 1 study of a drug that drives killer T cells into notoriously treatment-resistant pancreatic cancer.  The drug selicrelumab was given to 15 patients before their surgery and chemotherapy.  The excised tumor specimens were T-cell enriched and less fibrotic permitting better penetration of other therapeu